Polygenic Contributions to Lithium Augmentation Outcomes in Unipolar Depression.
Saved in:
| Title: | Polygenic Contributions to Lithium Augmentation Outcomes in Unipolar Depression. |
|---|---|
| Authors: | Kraft J; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; German Center for Mental Health (DZPG), partner site Berlin/Potsdam, Berlin, Germany., Buspavanich P; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.; German Center for Mental Health (DZPG), partner site Berlin/Potsdam, Berlin, Germany.; Charité Center for Prevention, Health and Human Sciences, Charité - Universitätsmedizin Berlin, Berlin, Germany., Braun A; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; German Center for Mental Health (DZPG), partner site Berlin/Potsdam, Berlin, Germany., Panagiotaropoulou G; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; German Center for Mental Health (DZPG), partner site Berlin/Potsdam, Berlin, Germany., Schlattmann P; Charité Center for Prevention, Health and Human Sciences, Jena University Hospital, Jena, Germany., Buchbauer H; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany., Heilbron K; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; German Center for Mental Health (DZPG), partner site Berlin/Potsdam, Berlin, Germany.; Pharmaceuticals, Research & Development, Bayer AG, Berlin, Germany., Heilbronner U; Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany., Schulze TG; Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Munich, Germany.; Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, New York.; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.; German Center for Mental Health (DZPG), partner site Munich/Augsburg, Berlin, Germany., Ripke S; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; German Center for Mental Health (DZPG), partner site Berlin/Potsdam, Berlin, Germany., Ricken R; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany., Adli M; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.; Fliedner Klinik Berlin, Centre for Psychiatry, Psychotherapy and Psychosomatic Medicine, Berlin, Germany. |
| Source: | JAMA psychiatry [JAMA Psychiatry] 2025 Nov 01; Vol. 82 (11), pp. 1137-1141. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print Cited Medium: Internet ISSN: 2168-6238 (Electronic) Linking ISSN: 2168622X NLM ISO Abbreviation: JAMA Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6238 |
|---|---|
| DOI: | 10.1001/jamapsychiatry.2025.2039 |
